Matrix Metalloproteinase 3
"Matrix Metalloproteinase 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extracellular endopeptidase of vertebrate tissues similar to MATRIX METALLOPROTEINASE 1. It digests PROTEOGLYCAN; FIBRONECTIN; COLLAGEN types III, IV, V, and IX, and activates procollagenase. (Enzyme Nomenclature, 1992)
| Descriptor ID |
D019278
|
| MeSH Number(s) |
D08.811.277.656.300.480.525.700.200 D08.811.277.656.675.374.525.700.200 D12.644.276.848.200 D12.776.467.836.200
|
| Concept/Terms |
Matrix Metalloproteinase 3- Matrix Metalloproteinase 3
- Metalloproteinase 3, Matrix
- Transin
- MMP3 Metalloproteinase
- Metalloproteinase, MMP3
- Stromelysin 1
- MMP-3 Metalloproteinase
- MMP 3 Metalloproteinase
- Metalloproteinase, MMP-3
- Stromelysin
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 3".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 3".
This graph shows the total number of publications written about "Matrix Metalloproteinase 3" by people in this website by year, and whether "Matrix Metalloproteinase 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 3" by people in Profiles.
-
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front Immunol. 2021; 12:593595.
-
Increase in Blood-Brain Barrier (BBB) Permeability Is Regulated by MMP3 via the ERK Signaling Pathway. Oxid Med Cell Longev. 2021; 2021:6655122.
-
Association of synovial inflammation and inflammatory mediators with glenohumeral rotator cuff pathology. J Shoulder Elbow Surg. 2016 Jun; 25(6):989-97.
-
Relationship of relaxin hormone and thumb carpometacarpal joint arthritis. Clin Orthop Relat Res. 2014 Apr; 472(4):1130-7.
-
Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study. Breast Cancer Res Treat. 2012 Dec; 136(3):837-45.
-
Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling. Arthritis Rheum. 2009 Nov; 60(11):3229-40.
-
Keratectasia after laser in situ keratomileusis: a histopathologic and immunohistochemical study. Arch Ophthalmol. 2008 Dec; 126(12):1655-63.
-
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Mod Pathol. 2006 Apr; 19(4):533-40.
-
HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res. 2004 Aug 01; 64(15):5283-90.
-
IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J Immunol. 2003 Jan 15; 170(2):838-45.